Liquid medicine concentration device

By using a water pump to clean residual drug solution from the inner wall of the tank and activated carbon to adsorb harmful gases, the drug solution concentration equipment solves the problem of residual substances in the drug solution concentration equipment affecting product quality, achieves stability and consistency of product purity and concentration, and reduces safety risks in biopharmaceuticals.

CN224573222UActive Publication Date: 2026-07-31HEBEI JOYCOME PHARM CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Utility models(China)
Current Assignee / Owner
HEBEI JOYCOME PHARM CO LTD
Filing Date
2025-06-21
Publication Date
2026-07-31

AI Technical Summary

Technical Problem

The residual active ingredients and impurities in existing drug concentration equipment can cause an imbalance in the composition ratio of different batches of products, posing a safety risk, especially in biopharmaceuticals where it may cause allergic reactions or medication safety issues.

Method used

A pharmaceutical liquid concentration device was designed. It uses a water pump to clean the residual pharmaceutical liquid on the inner wall of the tank, uses activated carbon to adsorb harmful gases, and automatically replaces the activated carbon when it becomes ineffective, ensuring that each batch of product is prepared in the same production environment and maintaining the consistency of product purity and concentration.

Benefits of technology

Effectively removes residual chemicals, preventing product formulation ratios and quality standards from being affected, ensuring product quality stability and consistency, reducing the risk of microbial growth, and improving product safety.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN224573222U_ABST
    Figure CN224573222U_ABST
Patent Text Reader

Abstract

This utility model discloses a pharmaceutical liquid concentration device, which includes a base, a water storage tank fixedly connected to the top of the base, a water inlet pipe fixedly connected to the top of the water storage tank, a water pump fixedly connected to the outside of the water inlet pipe, a tank body fixedly connected to the top of the base, a motor fixedly connected to the top of the tank body, a drive rod rotatably connected to the output end of the motor, and multiple first connecting rods fixedly connected to the outside of the drive rod. With this structure, residual pharmaceutical liquid may adhere to the surface inside the tank. The water pump then draws water from the water storage tank through the water inlet pipe into a ring-shaped water pipe inside the tank body, and the inner wall of the tank is cleaned by a nozzle at the bottom. This ensures that each batch of product is prepared in the same production environment, avoiding the influence of residual substances on the product's formula ratio and quality standards, ensuring that key indicators such as product purity and concentration meet requirements, and maintaining the stability and consistency of product quality.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This utility model relates to the field of pharmaceutical concentration technology, and in particular to a pharmaceutical concentration device. Background Technology

[0002] Pharmaceutical concentration equipment is a specialized device used to evaporate and remove solvents such as water and ethanol from pharmaceutical solutions, thereby increasing the concentration of solutes such as active ingredients and active substances in the solution. Its core function is to accelerate solvent evaporation through heating, depressurization, and other methods, concentrating the pharmaceutical solution from a low concentration to the required high concentration. It is widely used in the pharmaceutical, traditional Chinese medicine extraction, chemical, and food industries.

[0003] However, residual active ingredients, excipients, or impurities in some devices can mix with subsequent batches of medication, leading to an imbalance in the proportions of ingredients in different batches. If the residual medication contains allergens (such as protein components) or specific chemicals (such as antibiotics), it can pose safety risks to subsequent products, especially in the production of biopharmaceuticals or sensitive preparations, causing allergic reactions or medication safety issues for patients. Utility Model Content

[0004] The purpose of this invention is to ensure that each batch of products is prepared in the same production environment, avoid the influence of residual substances on the product's formula ratio and quality standards, ensure that key indicators such as product purity and concentration meet the requirements, maintain the stability and consistency of product quality, and provide a drug concentration device that solves the problem that the nutrients in residual drug solutions provide a growth environment for microorganisms, especially when the equipment is shut down or not thoroughly cleaned, bacteria, fungi and other microorganisms may multiply in large numbers.

[0005] This utility model also provides a pharmaceutical liquid concentration device as described above, including a base, a water storage tank fixedly connected to the top of the base, a water inlet pipe fixedly connected to the top of the water storage tank, a water pump fixedly connected to the outside of the water inlet pipe, a tank body fixedly connected to the top of the base, a motor fixedly connected to the top of the tank body, a drive rod rotatably connected to the output end of the motor, and a plurality of first connecting rods fixedly connected to the outside of the drive rod.

[0006] According to the present invention, a liquid concentration device is provided, wherein one end of the first connecting rod is fixedly connected to an annular water pipe, and the top of the annular water pipe is fixedly connected to one end of the inlet pipe.

[0007] According to the present invention, a pharmaceutical liquid concentration device is provided, wherein multiple stirring rods are fixedly connected to the outside of the drive rod, and two fixing blocks are fixedly connected to the outside of the tank.

[0008] According to the present invention, a liquid concentration device is provided, wherein a rotating rod is rotatably connected inside the fixed block, and a collar is rotatably connected outside the rotating rod.

[0009] According to the present invention, a liquid concentration device is provided, wherein a port is fixedly connected to the top of the tank, and two sliding grooves are fixedly connected inside the tank, and a filter plate is slidably connected inside the sliding grooves.

[0010] According to the present invention, a liquid medicine concentration device is provided, wherein a feed pipe is fixedly connected to the outside of the tank, a valve is fixedly connected to the outside of the feed pipe, and a receiving tank is fixedly connected to one end of the feed pipe.

[0011] According to the present invention, a liquid medicine concentration device is provided, wherein a vent pipe is fixedly connected to the outside of the tank, a vacuum pump is fixedly connected to the outside of the vent pipe, and a box is fixedly connected to one end of the vent pipe.

[0012] According to the present invention, a pharmaceutical liquid concentration device is provided, wherein two springs are fixedly connected inside the housing, a sliding plate is fixedly connected outside the springs, a second connecting rod is fixedly connected outside the sliding plate, a sliding rod is fixedly connected to the top of the second connecting rod, and activated carbon is provided inside the housing. Beneficial effects

[0013] 1. In the portable conical grinding machine of this technical solution, residual medicine may adhere to the surface inside the tank. At this time, water from the water tank is pumped through the water inlet pipe into the annular water pipe inside the tank, and the inner wall of the tank is cleaned through the nozzle at the bottom. This ensures that each batch of products is prepared in the same production environment, avoids the influence of residual substances on the product formula ratio and quality standards, ensures that the key indicators such as purity and concentration of the product meet the requirements, and maintains the stability and consistency of product quality.

[0014] 2. Harmful gases may leak out of the liquid medicine. At this time, the general-purpose vacuum pump will draw the gas into the chamber through the ventilation pipe and adsorb it by the activated carbon. When the activated carbon loses its adsorption capacity, the sliding rod can be slid to move the second connecting rod at the bottom, which will drive the sliding plate at one end to move. Under the elastic action of the spring, the sliding plate will remove the activated carbon inside the chamber and replace it. Attached Figure Description

[0015] The present invention will be further described below with reference to the accompanying drawings and embodiments; Figure 1 This is a structural diagram of the pharmaceutical liquid concentration equipment of this utility model; Figure 2 This is a schematic diagram of the water storage tank of the pharmaceutical liquid concentration equipment of this utility model; Figure 3 This is a schematic diagram of the structure of the stirring rod in the pharmaceutical liquid concentration device of this utility model; Figure 4This is a schematic diagram of the activated carbon structure in the pharmaceutical liquid concentration equipment of this utility model.

[0016] Legend: 1. Base; 2. Tank; 3. Port; 4. Fixing block; 5. Rotating rod; 6. Vent pipe; 7. Vacuum pump; 8. Box; 9. Feed pipe; 10. Valve; 11. Storage tank; 12. Collar; 13. Water tank; 14. Water inlet pipe; 15. Water pump; 16. Motor; 17. Drive rod; 18. Stirring rod; 19. First connecting rod; 20. Annular water pipe; 21. Slide groove; 22. Filter plate; 23. Activated carbon; 24. Spring; 25. Sliding plate; 26. Second connecting rod; 27. Slide rod. Detailed Implementation

[0017] This section will describe in detail the specific embodiments of the present utility model. The preferred embodiments of the present utility model are shown in the accompanying drawings. The purpose of the drawings is to supplement the textual description with graphics, so that people can intuitively and vividly understand each technical feature and the overall technical solution of the present utility model, but they should not be construed as limiting the scope of protection of the present utility model.

[0018] Reference Figure 1-4 This utility model provides a pharmaceutical liquid concentration device, which includes a base 1, a water storage tank 13 fixedly connected to the top of the base 1, a water inlet pipe 14 fixedly connected to the top of the water storage tank 13, a water pump 15 fixedly connected to the outside of the water inlet pipe 14, a tank body 2 fixedly connected to the top of the base 1, a motor 16 fixedly connected to the top of the tank body 2, a drive rod 17 rotatably connected to the output end of the motor 16, and a plurality of first connecting rods 19 fixedly connected to the outside of the drive rod 17.

[0019] Specifically, water from the storage tank 13 is pumped by the water pump 15 into the annular water pipe 20 inside the tank body through the inlet pipe 14, and the inner wall of the tank body 2 is cleaned by the nozzle at the bottom.

[0020] One end of the first connecting rod 19 is fixedly connected to an annular water pipe 20, and the top of the annular water pipe 20 is fixedly connected to one end of the inlet pipe 14.

[0021] Multiple stirring rods 18 are externally fixed to the drive rod 17, and two fixing blocks 4 are externally fixed to the tank body 2.

[0022] Specifically, the motor 16 drives the external stirring rod 18 to rotate, thereby stirring the liquid medicine.

[0023] The fixed block 4 is internally connected to a rotating rod 5, and the rotating rod 5 is externally connected to a collar 12.

[0024] The top of the tank 2 is fixedly connected to a port 3, and the inside of the tank 2 is fixedly connected to two slide grooves 21, with a filter plate 22 slidably connected inside the slide grooves 21.

[0025] A feed pipe 9 is fixedly connected to the outside of the tank body 2. A valve 10 is fixedly connected to the outside of the feed pipe 9. A collection tank 11 is fixedly connected to one end of the feed pipe 9.

[0026] Specifically, valve 10 is opened to allow the liquid medicine to enter the collection tank 11 through the feed pipe 9.

[0027] A vent pipe 6 is fixedly connected to the outside of the tank 2, and an air pump 7 is fixedly connected to the outside of the vent pipe 6. One end of the vent pipe 6 is fixedly connected to the box body 8.

[0028] Specifically, the gas is drawn into the chamber 8 through the vent pipe 6 by the vacuum pump 7.

[0029] The box body 8 has two springs 24 fixedly connected inside, and a sliding plate 25 fixedly connected to the outside of the springs 24. A second connecting rod 26 is fixedly connected to the outside of the sliding plate 25. A sliding rod 27 is fixedly connected to the top of the second connecting rod 26. Activated carbon 23 is installed inside the box body 8.

[0030] Specifically, activated carbon 23 adsorbs the activated carbon. When the activated carbon 23 loses its adsorption capacity, the sliding rod 27 causes the second connecting rod 26 at the bottom to move the sliding plate 25 at one end. Under the elastic action of the spring 24, the sliding plate 25 removes the activated carbon 23 inside the box 8 and replaces it.

[0031] Working principle: The liquid medicine is poured into the tank 2 through port 3. Driven by motor 16 and drive rod 17, the external stirring rod 18 rotates to stir the liquid medicine. Then, valve 10 is opened to let the liquid medicine flow into the collection tank 11 through the feed pipe 9. There will be residual liquid medicine adhering to the surface inside the tank 2. At this time, water pump 15 draws water from water tank 13 into the annular water pipe 20 inside the tank through water inlet pipe 14. The inner wall of the tank 2 is cleaned through the nozzle at the bottom. This ensures that each batch of product is prepared in the same production environment and avoids contamination. Residual substances affect the product's formula ratio and quality standards. To ensure that key indicators such as product purity and concentration meet requirements and maintain product quality stability and consistency, harmful gases may leak out of the liquid medicine. At this time, the gas is drawn into the box 8 through the ventilation pipe 6 by the vacuum pump 7 and adsorbed by the activated carbon 23. When the activated carbon 23 loses its adsorption properties, the sliding rod 27 causes the second connecting rod 26 at the bottom to move the sliding plate 25 at one end. Under the elastic action of the spring 24, the sliding plate 25 removes the activated carbon 23 inside the box 8 and replaces it.

[0032] The embodiments of the present utility model have been described in detail above with reference to the accompanying drawings. However, the present utility model is not limited to the above embodiments. Within the scope of knowledge possessed by those skilled in the art, various changes can be made without departing from the spirit of the present utility model.

Claims

1. A drug solution concentration device comprising a base (1), characterized in that: A water storage tank (13) is fixedly connected to the top of the base (1), an inlet pipe (14) is fixedly connected to the top of the water storage tank (13), a water pump (15) is fixedly connected to the outside of the inlet pipe (14), a tank body (2) is fixedly connected to the top of the base (1), a motor (16) is fixedly connected to the top of the tank body (2), a drive rod (17) is rotatably connected to the output end of the motor (16), and a plurality of first connecting rods (19) are fixedly connected to the outside of the drive rod (17).

2. The pharmaceutical liquid concentration apparatus according to claim 1, wherein One end of the first connecting rod (19) is fixedly connected to an annular water pipe (20), and the top of the annular water pipe (20) is fixedly connected to one end of the inlet pipe (14).

3. The pharmaceutical liquid concentrating apparatus according to claim 1, wherein The drive rod (17) is externally fixedly connected to multiple stirring rods (18), and the tank (2) is externally fixedly connected to two fixing blocks (4).

4. The pharmaceutical solution concentration apparatus according to claim 3, wherein The fixed block (4) is rotatably connected to a rotating rod (5) inside, and a collar (12) is rotatably connected to the outside of the rotating rod (5).

5. The pharmaceutical liquid concentration device according to claim 1, characterized in that, The top of the tank (2) is fixedly connected to a port (3), and the inside of the tank (2) is fixedly connected to two slide grooves (21), and a filter plate (22) is slidably connected inside the slide grooves (21).

6. The pharmaceutical solution concentration apparatus according to claim 1, wherein The tank (2) is fixedly connected to a feed pipe (9), and a valve (10) is fixedly connected to the outside of the feed pipe (9). One end of the feed pipe (9) is fixedly connected to a storage tank (11).

7. The pharmaceutical solution concentration apparatus according to claim 1, wherein A vent pipe (6) is fixedly connected to the outside of the tank (2), and an air pump (7) is fixedly connected to the outside of the vent pipe (6). A box body (8) is fixedly connected to one end of the vent pipe (6).

8. The pharmaceutical solution concentration apparatus according to claim 7, wherein The box (8) is internally fixedly connected to two springs (24), and externally fixedly connected to the springs (24) are sliding plates (25). Externally fixedly connected to the sliding plates (25) are second connecting rods (26). Top of the second connecting rods (26) is fixedly connected to a sliding rod (27). Activated carbon (23) is provided inside the box (8).